June 14, 2002 -- Recombinant fibroblast growth factor-2 (rFGF-2) may enhance angiogenesis and improve severe claudication in patients at high risk for amputation or in whom bypass is not feasible, ...
Results of a study in this week's issue of THE LANCET highlight the potential for angiogenic therapy—the use of genes, proteins, and other molecular agents to stimulate growth of new blood vessels—to ...
DURHAM, N.C. -- In the first demonstration of the therapeutic benefit of an agent that stimulates blood vessel growth, a group of cardiologists have improved the functional abilities of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results